Whitebox Advisors LLC Organon & Co. Transaction History

Whitebox Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $779,730 - $1.12 Million	-47,000 Reduced 34.73%	88,343 $1.53 Million
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $1.62 Million - $2.07 Million	84,119 Added 164.22%	135,343 $2.82 Million
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $316,600 - $389,000	-10,000 Reduced 16.33%	51,224 $1.73 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $1.4 Million - $1.81 Million	-45,937 Reduced 42.87%	61,224 $2.14 Million
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $1.11 Million - $1.44 Million	38,797 Added 56.75%	107,161 $3.26 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $200,410 - $249,480	-7,000 Reduced 9.29%	68,364 $2.24 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $2.14 Million - $2.86 Million	75,364 New	75,364 $2.28 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Whitebox Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Whitebox Advisors LLC with notifications on news.